).png)
MEET THE AUTHORS:
Jack Williams, PhD - Consultant
Jack Williams, PhD, is a Consultant at Lucid Strategy Consulting, specializing in asset strategy, market access, and evidence generation in complex therapeutic areas. He uses his extensive academic background to turn scientific potential into commercial success and improved patient outcomes.
jack.williams@wearelucidgroup.com
MEET THE AUTHORS:
Helen Stewart - Executive Scientific Director
Helen Stewart is an Executive Scientific Director at Lucid Group who combines strong scientific storytelling with a commercial mindset, enabling her to translate complex data into clear, relevant insights that support decision-making. Helen has experience partnering with Medical Affairs, Commercial, and wider cross-functional teams, at multinational pharmaceuticals, biotech start-ups, and medical diagnostics companies.
helen.stewart@wearelucidgroup.com
MEET THE AUTHORS:
Simon Bates - President, Consulting
Simon Bates is President of Lucid Strategy Consulting. He has extensive experience supporting pharma companies’ commercial strategies. He has particular expertise in innovative market models and “beyond the pill” strategies such as companion diagnostics, population health, digital health and HCP/patient support solutions in metabolic, renal, neurodegenerative and other disease areas.
MEET THE AUTHORS:
Dr. Aprit Srivastava
Dr. Srivastava is a General Practitioner, a member of the NICE Technology Appraisals Committee, and the founder of messageGP.com. He combines extensive experience in prescribing GLP-1s with deep insight into daily clinical practice, allowing him to navigate the complex challenges faced in managing metabolic dysfunction. Dr. Srivastava bridges front-line patient care with health technology assessment, bringing a practical yet strategic perspective to healthcare innovation.
About Lucid Strategy Consulting
Turning complexity into measurable value across life sciences.
At Lucid Strategy Consulting, we combine business insight with deep life sciences expertise to deliver impact for our pharma, biotech and medtech clients. We help leaders unlock the full potential of their assets, create new value for their customers, drive better outcomes and experiences for patients, and transform internal operations to succeed in a changing external environment.
Access the GLP-1 Whitepaper
A strategic perspective on the evolving GLP-1 landscape, exploring the insights and considerations shaping the future of obesity care.